RE: US Deal21 Apr 2025 11:51
Yes, I agree s/w
If world class pharmaceuticals are in demand, by the same measure, and if Trump's bullying can be sidestepped, theoretically there is strategic logic in using Abu Dhabi as a distribution hub for pharmaceuticals heading to China (future projection). Even though it might not be the most obvious route. Abu Dhabi’s geographic location is a key advantage, with Khalifa Port providing direct access to major maritime routes, including those leading to China. This proximity makes the UAE a natural logistical hub for goods destined for the Chinese market.
For UK pharmaceutical companies, distributing through Abu Dhabi it offers several benefits. It provides access to modern infrastructure, cost advantages, and a stable, favorable regulatory environment. Additionally, Abu Dhabi’s location brings them closer to China’s vast market. However, UK firms will need to navigate China’s complex regulatory and competitive landscape carefully.
Despite China having a strong domestic pharmaceutical industry, there is a growing demand for international brands, particularly for innovative drugs used in treating complex diseases like cancer, diabetes, and cardiovascular conditions. This creates a promising opportunity for UK companies looking to tap into China’s expanding pharmaceutical market. This is obviously only theoretical, but the UK has a good set of cards to play any games.